Pontifax Management 4 G.P. (2015) Ltd., 10% Owner at Eloxx Pharmaceuticals, Inc. (ELOX), bought 700,000 shares at $9.75 ($6.8M) on 2018-04-30, disclosed to the SEC on 2018-05-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.75 | 84,041 | $819K | 12.0% |
| 2 | $9.75 | 84,041 | $819K | 12.0% |
| 3 | $9.75 | 93,333 | $910K | 13.3% |
| 4 | $9.75 | 93,333 | $910K | 13.3% |
| 5 | $9.75 | 172,626 | $1.7M | 24.7% |
| 6 | $9.75 | 172,626 |
| $1.7M |
| 24.7% |
| Total | $9.75 avg | 700,000 | $6.8M | 100% |
| Filing → |
| ETNB | BUY | 2019-11-13 | $4.0M | — | Filing → |
| ELOX | BUY | 2019-06-26 | $1.8M | — | Filing → |
| ELOX | BUY | 2018-03-23 | $98K | — | Filing → |